TrialFind
Saved trials
Back to results
Completed
Phase 3
An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018
NCT00199368
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Kyowa Pharmaceutical Inc.
Princeton, New Jersey, United States
View on ClinicalTrials.gov
Official details
An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018 — TrialFind